Skip to main content
HR 1201 105th Congress House Health Ambulatory care Civil Rights and Liberties, Minority Issues Commerce Communication in medicine Computer software Congress Congressional reporting requirements Consumer education Cost effectiveness Disabled Drug interactions Drug utilization Drugs Drugstores Electronic data interchange Emblems Finance and Financial Sector Generic drugs Government Operations and Politics

Medicare Medication Evaluation and Dispensing System Act of 1997

Introduced: March 20, 1997 See on congress.gov
 Everywhere this bill has been 7 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 1, 1997
Sponsor introductory remarks on measure. (CR E810-811)
Apr 4, 1997
Referred to the Subcommittee on Health and Environment, for a period to be subsequently determined by the Chairman.
Mar 21, 1997
Sponsor introductory remarks on measure. (CR E547-548)
Mar 20, 1997
Referred to House Commerce
Mar 20, 1997
Referred to the Committee on Ways and Means, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 20, 1997
Referred to House Ways and Means
Mar 20, 1997
Introduced in House
 Plain-English summary Congressional Research Service

Medicare Medication Evaluation and Dispensing System Act of 1997 - Amends title XVIII (Medicare) of the Social Security Act to require the Secretary of Health and Human Services to establish and operate the Medicare Medication Evaluation and Dispensing System (MMEDS) to provide for: (1) prospective and retrospective review of prescription drugs furnished to Medicare beneficiaries; (2) education of physicians, patients, and pharmacists in the appropriate use of prescription drugs; (3) the establishment of standards for counseling Medicare beneficiaries regarding the appropriate use of prescription drugs; and (4) review, information, and counseling with respect to any prescription drug furnished to a Medicare beneficiary without regard to whether or not payment may be made for the drug under Medicare. Sets forth requirements for review of prescriptions.

Directs the Secretary to establish: (1) a point-of-sale electronic system for carriers and pharmacists to use in submitting information on outpatient prescription drugs dispensed to Medicare patients; and (2) standards to protect from public disclosure any MMEDS-provided information identifying individuals with respect to their physical or mental health.

Requires the Secretary to report to the Congress: (1) an analysis of the effect on net aggregate Medicare expenditures from the establishment of such a System; and (2) any recommendations on Medicare coverage of pharmacist professional services.

Directs the Secretary to publish and disseminate a consumer guide to outpatient prescription drugs to assist: (1) Medicare beneficiaries in reducing expenditures for them; and (2) individuals and entities furnishing items and services to such beneficiaries in determining the cost-effectiveness of such drugs.

What's happening now May 1, 1997

Sponsor introductory remarks on measure. (CR E810-811)

 Committees of jurisdiction 3